Unitree Robotics' $618M IPO Is the First Real Market Test for Humanoid Hardware

China's securities regulator cleared the Unitree Robotics IPO on July 3, 2026, greenlighting a roughly 4.2 billion yuan (about $618 million) raise on Shanghai's STAR Market at an implied valuation near 40 billion yuan, or $5.9 billion. According to Caixin Global, the CSRC signed off after receiving the Shanghai Stock Exchange's review opinion and Unitree's registration documents, positioning the Hangzhou company for a listing debut reported as early as late July.

This is the first time public markets get to price a pure-play humanoid robot maker that is actually shipping hardware in volume and turning a profit doing it. Everything else in the category, from Figure to 1X to Tesla's Optimus program, is still private, still burning cash, or still a line item inside a much larger business.

The listing lands at a moment when embodied AI has become one of the most hyped categories in venture capital, yet almost none of that hype has been forced to meet the discipline of daily mark-to-market pricing. Unitree changes that.

Why a 104-Day Approval Matters More Than the Headline Number

The speed of the process is the tell. Markman Capital Insight reports that Shanghai regulators cleared the deal in 104 days, described as the fastest STAR Market review on record. RoboZaps frames the July 3 registration approval the same way, calling it the fastest STAR registration ever.

Regulatory speed in China is a policy signal. Beijing has spent two years pushing embodied AI as a strategic industry, and the STAR board was built to fast-track exactly this kind of company. A humanoid robot manufacturer with real revenue and a domestic supply chain is the archetype the exchange was designed to list.

The Caixin report confirms competing Chinese robotics firms Deep Robotics and Leju Robotics are also pursuing A-share listings, turning what would otherwise be a single event into the opening move of a sector rush. That queue changes the read of Unitree's approval. It is not a one-off exception; it is the first pass through a pipeline the regulator wants moving.

For foreign observers used to SEC-style timelines, 104 days from filing to approval on a company with a dual-class share structure and an emerging-industry classification is remarkable. It also means the review depth may be shallower than a comparable U.S. process, which matters for how much of the risk disclosure investors should treat as fully vetted.

The Numbers Underwriters Are Selling

Unitree is the rare hardware startup that arrives at its IPO already profitable. TechMarket Briefs, citing the company's prospectus, reports 2025 revenue of 1.708 billion yuan, up 335 percent year on year, with a 60.27 percent gross margin and adjusted net profit of 600.1 million yuan. That gross margin is the pitch. It sits above where most listed service robotics peers land.

Revenue growth has been vertical. Markman Capital Insight tracks the climb from 159 million yuan in 2023 to roughly 1.7 billion yuan in 2025, a tenfold jump in two years. Founded in 2016, Unitree reported 2025 revenue of 1.69 billion yuan, per Caixin, against 123 million yuan in 2022.

The mix shift is the more important story inside those totals. TechMarket Briefs shows humanoids climbing from 27.6 percent of revenue in 2024 to 51.5 percent in the first nine months of 2025, overtaking the quadruped business that made Unitree famous. A company that sold robot dogs to universities two years ago now sells bipeds to enterprises as its primary product line.

Unit volume backs the mix shift. TechMarket Briefs reports Unitree shipped more than 5,500 humanoid robots in 2025, and the prospectus claims a 32.4 percent global share of unit humanoid shipments. Share claims from a company's own filing deserve scrutiny, but the absolute unit number is large relative to any Western competitor with disclosed shipping figures.

The control structure is worth flagging for anyone buying shares. Founder Wang Xingxing enters the listing with 68.78 percent of voting rights through Class A shares carrying 10 votes each, TechMarket Briefs reports. CITIC Securities is sponsor and lead underwriter.

The Price Collapse Nobody in the Prospectus Wants to Dwell On

Here is the figure most bullish coverage buries. Unitree's average humanoid selling price fell from roughly 593,400 yuan (about $85,000) in 2023 to around 167,600 yuan (about $23,000) by 2025, according to TechMarket Briefs. That is a 72 percent drop in average price over two years.

Revenue still grew because unit volume grew faster than price fell. But a compounding price decline of that magnitude is the defining risk in the story. RoboZaps lists the G1 humanoid at $13,500 as of July 16, 2026, with the R1 starting at $4,900 and the Go2 robot dog ranging $1,600 to $4,500. The H1 lists at $90,000 and the H2 at $29,900, both with checkout disabled.

A public shareholder is buying into a company whose product-line ASP is falling faster than most listed hardware categories have ever fallen. Smartphones took a decade to compress the way humanoids have compressed in 24 months. The question the STAR debut answers is whether investors will underwrite that trajectory as commoditization-at-scale or as margin destruction.

There is a bull case buried inside the price collapse. If the addressable market for a $13,500 general-purpose humanoid is an order of magnitude larger than the market for an $85,000 research platform, the ASP drop is the mechanism by which Unitree unlocks industrial deployment. The bear case is simpler: a 60 percent gross margin cannot survive another 50 percent price cut without matching cost-out on the bill of materials, and Chinese competitors are entering the same segment with similar cost structures.

What UBTech Already Showed the Market About a Humanoid Robot Stock in China

There is one prior data point for pricing a humanoid robot stock China investors can actually trade, and it is not encouraging. UBTech was the first humanoid robot company to go public, listing on the Hong Kong main board in December 2023, according to Markman Capital Insight, which describes its volatile three-year post-listing track record as the clearest precedent for what Unitree faces.

That precedent complicates the bullish story. UBTech went public without profitability and has traded on narrative rather than earnings. Unitree lists with a real income statement, but it also lists into a market that has already watched one humanoid stock roundtrip through several cycles of hype and disappointment.

KraneShares valued Unitree at roughly $1.7 billion in a mid-2025 funding round; the IPO targets $3 billion to $7 billion, implying a forward price-to-sales multiple in the low-to-mid 20s at the low end of that range. Comparable robotics names on the STAR and ChiNext boards cluster around mid-teens revenue multiples, though select high-growth leaders trade higher.

The premium is defensible only if the 60 percent gross margin holds through the next price cut cycle. If it does not, the multiple compresses fast.

Who Actually Gets to Buy It

Most international readers can't. The STAR Market listing is inaccessible to most non-Chinese retail investors at debut, RoboZaps notes, a caveat that gets left out of most English-language coverage. Access for foreign capital runs through Stock Connect eligibility, qualified institutional programs, or ETFs that hold STAR-listed names as underlying positions.

That means the price discovery in the first days of trading will be dominated by Chinese retail and domestic institutional flow, not global funds. Anyone modeling comparables against Nasdaq-listed robotics names is looking at two different investor bases. KraneShares points to Chinese robotics peers including AgiBot, UBTech, Fourier Intelligence, and Xiaomi's CyberOne platform, most of which are already listed or in the queue.

Recent robotics and AI-adjacent IPOs on the A-share market have shown wide post-listing dispersion, KraneShares reports, with some delivering strong returns and others steep drawdowns. Investor selectivity is high. This is not 2020.

For readers looking at exposure through vehicles they can actually own, the practical route is thematic ETFs that hold STAR-listed constituents. KraneShares highlights its own STAR Market ETF (KSTR) and humanoid robotics ETF (KOID) as products that could take positions once liquidity criteria and index inclusion rules are met. Index inclusion typically requires a minimum trading history, so a Unitree ETF weight is not day-one exposure.

The Detail Missing From Most Coverage

One fact keeps getting stripped out of Western reporting: Unitree signed the 2022 open letter against weaponizing general-purpose robots, alongside Boston Dynamics and four other robotics firms, per RoboZaps. That directly contradicts the reflexive framing of Unitree as an unbound Chinese rival to Western robotics companies operating under different ethical constraints.

Whether that signature holds up under listed-company pressure is a separate question. Public companies with growth expectations attached to defense-adjacent contracts have historically softened these positions. It's the sort of governance question that matters more once shares trade daily and revenue guidance gets scrutinized quarterly.

The other underdiscussed angle is customer concentration. The prospectus figures reported by TechMarket Briefs describe rapid revenue growth but do not, in the public excerpts, break out how much of the 2025 humanoid revenue came from repeat industrial buyers versus research-lab one-offs and developer units. A 5,500-unit shipment number that is heavily weighted toward developer kits at sub-$15,000 price points is a different business from 5,500 units deployed on factory floors under multiyear service contracts.

Readers following the broader shift toward physical AI systems can track related coverage in the Physical AI articles section, and the corporate finance side alongside recent moves like DeepSeek's valuation leap and TSMC's Arizona commitment.

What to Watch in the Next 30 Days

Three specific things will determine whether the debut clears expectations. Pricing terms first: RoboZaps reports Unitree is finalizing pricing to sell at least 40.45 million shares, representing at least a 10 percent stake. The final range will reveal whether underwriters priced at the low end of the $3 billion to $7 billion valuation band or pushed higher.

Second, the first quarterly print as a listed entity. A second consecutive quarter of margin compression would break the profitability narrative underwriters are selling. The 60.27 percent gross margin cited by TechMarket Briefs is the anchor of the valuation case, and any softening in that number under listed-company disclosure would compress the multiple faster than any single line item on the P&L.

Third, the response from Deep Robotics and Leju Robotics. If either files revised terms after Unitree prices, the sector is being repriced in real time. The Robotics & Drones articles hub tracks these filings as they land.

The listing date itself remains the near-term marker. RoboZaps and multiple Chinese outlets have reported a debut as early as late July 2026, though the company has not confirmed a specific trading date.